About this Research Topic
Non-communicable diseases such as heart disease, diabetes and liver disease all present with both organ-specific and extra-organ manifestations that can result in poorer outcomes and downstream consequences. The advances in quantitative imaging allow for the integrated assessment of the organs related to pathology to augment the clinical presentation and to advance towards personalised medicine. This has been particularly relevant in the wake of COVID-19, which has highlighted a key need for further integrative medical approaches to diagnostics. Whilst originally viewed as a respiratory disorder, there is growing evidence and concern for non-pulmonary impairment in those with ongoing symptoms which may be associated with damage to other vital organs and to pre-existing risk factors such as type 2 diabetes and fatty liver disease
This Research Topic is interested in articles examining cardiac and abdominal imaging techniques used in epidemiological, clinical, physiological and measurement-based studies, and on studies of extra pulmonary sequela of COVID-19 and other disease. Organ specific assessment can be made with medical imaging such as quantitative MRI which can be used to characterise the health of the tissue and may detect subtle changes and underlying conditions that may augment the clinical presentation and potentially aid in clinical decision making.
We particularly welcome contributions that include, but are not limited to, the following topics:
1) Systems physiology.
2) Interventions.
3) Epidemiology.
4) Population characteristics related to COVID-19.
5) Measurement considerations.
This Research Topic is interested in articles examining cardiac and abdominal imaging techniques used in epidemiological, clinical, physiological and measurement-based studies, and on studies of extra pulmonary sequela of COVID-19 and other disease. Organ specific assessment can be made with medical imaging such as quantitative MRI which can be used to characterise the health of the tissue and may detect subtle changes and underlying conditions that may augment the clinical presentation and potentially aid in clinical decision making.
We particularly welcome contributions that include, but are not limited to, the following topics:
1) Systems physiology.
2) Interventions.
3) Epidemiology.
4) Population characteristics related to COVID-19.
5) Measurement considerations.
Keywords: Imaging, Multi-organ, Personalised medicine, COVID-19, metabolic disease, hypertension
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
